New York, NY / ACCESSWIRE / January 7, 2015 / NeoStem, Inc. (NASDAQ: NBS) today published a new blog post on The Chairman's Blog, written by the Company's Executive Chairman, Dr. Robin L. Smith. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.

Dr. Smith introduced the newest additions to the management team, Dr. David J. Mazzo, NeoStem's new Chief Executive Officer, and Robert S. Vaters, NeoStem's new President and Chief Financial Officer. She wrote,"These are exciting times at NeoStem and we all look forward to this new chapter in the company's history." Read the full blog post from Dr. Robin L. Smith on TheChairmansBlog.com (http://www.thechairmansblog.com/neostem/robin-smith/strengthening-neostems-executive-management-two-significant-hires/).

About NeoStem, Inc.

NeoStem is a biopharmaceutical company pursuing the preservation and enhancement of human health globally through the development of cell based therapeutics that prevent, treat or cure disease by repairing and replacing damaged or aged tissue, cells and organs and restoring their normal function. The combination of a rich therapeutics pipeline and externally recognized in-house manufacturing expertise has created an organization with unique capabilities for cost effective and accelerated product development. www.neostem.com

About TheChairmansBlog.com

TheChairmansBlog.com is an exclusive, online media publication where publicly and privately held firms alike share insights about their companies and industries. TheChairmansBlog.com enables upper tier management to discuss issues that are of importance to their stakeholders, shareholders, and interested parties in an informal environment. www.thechairmansblog.com

SOURCE: TheChairmansBlog.com